277 related articles for article (PubMed ID: 12136249)
21. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation.
Minchenko O; Opentanova I; Minchenko D; Ogura T; Esumi H
FEBS Lett; 2004 Oct; 576(1-2):14-20. PubMed ID: 15474002
[TBL] [Abstract][Full Text] [Related]
23. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.
Katsuta M; Miyashita M; Makino H; Nomura T; Shinji S; Yamashita K; Tajiri T; Kudo M; Ishiwata T; Naito Z
Exp Mol Pathol; 2005 Apr; 78(2):123-30. PubMed ID: 15713437
[TBL] [Abstract][Full Text] [Related]
24. [Construction and expression analysis of recombinant vector pcDNA3.1+-HIF-1alpha].
Fu RB; Wu PS; Dai TY; Lai WY; Qiu J
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1134-6. PubMed ID: 14625170
[TBL] [Abstract][Full Text] [Related]
25. [Over-expression of HIF-1alpha induces EMT of human prostate cancer cells].
Luo Y; He DL; Jiang YG; Li MC; Ning L; Shen SL
Zhonghua Nan Ke Xue; 2008 Sep; 14(9):800-4. PubMed ID: 18998463
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.
Mirzoeva S; Kim ND; Chiu K; Franzen CA; Bergan RC; Pelling JC
Mol Carcinog; 2008 Sep; 47(9):686-700. PubMed ID: 18240292
[TBL] [Abstract][Full Text] [Related]
27. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
[TBL] [Abstract][Full Text] [Related]
28. Effects of lentivirus-mediated HIF-1alpha knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells.
Hao J; Song X; Song B; Liu Y; Wei L; Wang X; Yu J
Cancer Gene Ther; 2008 Jul; 15(7):449-55. PubMed ID: 18421307
[TBL] [Abstract][Full Text] [Related]
29. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
[TBL] [Abstract][Full Text] [Related]
30. Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells.
Thomas R; Kim MH
Biochem Biophys Res Commun; 2005 Aug; 334(2):543-8. PubMed ID: 16005427
[TBL] [Abstract][Full Text] [Related]
31. The homozygous P582S mutation in the oxygen-dependent degradation domain of HIF-1 alpha is associated with increased risk for prostate cancer.
Orr-Urtreger A; Bar-Shira A; Matzkin H; Mabjeesh NJ
Prostate; 2007 Jan; 67(1):8-13. PubMed ID: 16998808
[TBL] [Abstract][Full Text] [Related]
32. Over-expression of hypoxia-inducible factor-1alpha increases the invasive potency of LNCaP cells in vitro.
Luo Y; He DL; Ning L; Shen SL; Li L; Li X; Zhau HE; Chung LW
BJU Int; 2006 Dec; 98(6):1315-9. PubMed ID: 16956360
[TBL] [Abstract][Full Text] [Related]
33. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
[TBL] [Abstract][Full Text] [Related]
34. [Vector-mediated shRNA inhibits HIF-1alpha expression in prostate cancer cells].
Ping H; Xing NZ; Chen XC; Zhang JH; Yan-Yong ; Yang Y
Zhonghua Nan Ke Xue; 2008 Nov; 14(11):993-7. PubMed ID: 19102499
[TBL] [Abstract][Full Text] [Related]
35. Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer.
Kosaka T; Miyajima A; Shirotake S; Kikuchi E; Hasegawa M; Mikami S; Oya M
Prostate; 2010 Feb; 70(2):162-9. PubMed ID: 19760626
[TBL] [Abstract][Full Text] [Related]
36. Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells.
Harada H; Hiraoka M; Kizaka-Kondoh S
Cancer Res; 2002 Apr; 62(7):2013-8. PubMed ID: 11929818
[TBL] [Abstract][Full Text] [Related]
37. [Role of beta-catenin signaling pathway in EMT of human prostate cancer induced by HIF-1alpha].
Luo Y; He DL; Jiang YG; Ning L; Shen SL; Zhao JH; Cui XH
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(16):1131-6. PubMed ID: 20646434
[TBL] [Abstract][Full Text] [Related]
38. Expression of hypoxia inducible factor-1 alpha in matched hormone naive and castrate resistant prostate cancer specimens.
Elsberger B; Lankston L; Orange C; Underwood MA; Edwards J
Cancer Biomark; 2010-2011; 8(1):1-9. PubMed ID: 21896985
[TBL] [Abstract][Full Text] [Related]
39. Construction of recombinant adenovirus vector containing a modified gene that codes for human hypoxia-inducible factor-1alpha without oxygen-dependent degradation domain.
Wei L; Lu J; Feng L; Li S; Shan J; Li Y
Plasmid; 2010 Jan; 63(1):20-6. PubMed ID: 19766670
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional upregulation of MT2-MMP in response to hypoxia is promoted by HIF-1α in cancer cells.
Zhu S; Zhou Y; Wang L; Zhang J; Wu H; Xiong J; Zhang J; Tian Y; Wang C; Wu H
Mol Carcinog; 2011 Oct; 50(10):770-80. PubMed ID: 21751260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
